Sabra Health Care REIT (NASDAQ:SBRA) Issues Quarterly Earnings Results

Sabra Health Care REIT (NASDAQ:SBRA) posted its quarterly earnings data on Wednesday. The real estate investment trust reported $0.36 EPS for the quarter, hitting analysts’ consensus estimates of $0.36, Zacks reports. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. Sabra Health Care REIT updated its FY 2025 guidance to 1.430-1.460 EPS.

Sabra Health Care REIT Stock Up 0.5 %

Shares of SBRA stock traded up $0.09 on Wednesday, reaching $16.55. 2,383,460 shares of the company’s stock traded hands, compared to its average volume of 2,028,542. Sabra Health Care REIT has a 12-month low of $13.31 and a 12-month high of $20.03. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. The company has a market capitalization of $3.92 billion, a P/E ratio of 40.37, a price-to-earnings-growth ratio of 1.99 and a beta of 1.25. The business’s 50 day moving average price is $16.92 and its two-hundred day moving average price is $17.63.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 7.25%. Sabra Health Care REIT’s dividend payout ratio is 292.69%.

Analysts Set New Price Targets

A number of analysts have recently commented on SBRA shares. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research note on Tuesday, January 7th. Mizuho reissued a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, Truist Financial downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Three analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $18.86.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.